Baillie Gifford & Co. lowered its position in shares of Schrödinger, Inc. (NASDAQ:SDGR - Free Report) by 46.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,054,403 shares of the company's stock after selling 926,589 shares during the quarter. Baillie Gifford & Co. owned 1.45% of Schrödinger worth $20,339,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. KBC Group NV raised its holdings in shares of Schrödinger by 45.4% during the third quarter. KBC Group NV now owns 2,508 shares of the company's stock valued at $47,000 after acquiring an additional 783 shares during the period. GAMMA Investing LLC raised its holdings in shares of Schrödinger by 87.5% during the fourth quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock valued at $54,000 after acquiring an additional 1,305 shares during the period. Quarry LP raised its holdings in shares of Schrödinger by 1,150.0% during the third quarter. Quarry LP now owns 2,825 shares of the company's stock valued at $52,000 after acquiring an additional 2,599 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Schrödinger during the third quarter valued at approximately $102,000. Finally, Point72 DIFC Ltd acquired a new position in Schrödinger in the 3rd quarter valued at approximately $151,000. Institutional investors and hedge funds own 79.05% of the company's stock.
Analyst Ratings Changes
SDGR has been the topic of several research reports. KeyCorp upped their price objective on shares of Schrödinger from $25.00 to $27.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. BMO Capital Markets upped their price objective on shares of Schrödinger from $25.00 to $28.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $32.11.
Get Our Latest Stock Analysis on SDGR
Schrödinger Stock Down 5.7 %
Shares of SDGR traded down $1.36 during mid-day trading on Friday, hitting $22.64. 1,246,251 shares of the company's stock were exchanged, compared to its average volume of 998,259. The firm has a fifty day moving average of $22.19 and a two-hundred day moving average of $20.49. Schrödinger, Inc. has a twelve month low of $16.67 and a twelve month high of $33.63. The stock has a market cap of $1.65 billion, a price-to-earnings ratio of -9.68 and a beta of 1.61.
Schrödinger Company Profile
(
Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Featured Stories

Before you consider Schrödinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.
While Schrödinger currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.